会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • TRICYCLIC COMPOUND
    • 三聚体化合物
    • WO1994011375A1
    • 1994-05-26
    • PCT/JP1993001601
    • 1993-11-04
    • FUJISAWA PHARMACEUTICAL CO., LTD.SATO, YoshinariITANI, Hiromichi
    • FUJISAWA PHARMACEUTICAL CO., LTD.
    • C07D487/06
    • C07D487/06
    • A tricyclic compound useful as a medicine, represented by general formula (I), a pharmaceutically acceptable salt thereof, an intermediate therefor, a process for producing the same, and a cholecystokinin antagonist, wherein R represents hydrogen, carboxyl, protected carboxyl, carboxy(lower)alkyl, protected carboxy(lower)alkyl, carboxy(lower)alkanoyl, protected carboxy(lower)alkanoyl, carboxy(lower)alkenoyl, protected carboxy(lower)alkenoyl, optionally substitued heterocyclic carbonyl(lower)alkyl, or optionally substituted heterocyclic carbonyl(lower)alkanoyl; R represents optionally substituted aryl; and R represents acyl.
    • 用作药物的三环化合物,由通式(I)表示,其药学上可接受的盐,其中间体,其制备方法和缩胆囊素拮抗剂,其中R 1表示氢,羧基,被保护的羧基 ,羧基(低级)烷基,保护的羧基(低级)烷基,羧基(低级)烷酰基,保护的羧基(低级)烷酰基,羧基(低级)烯酰基,被保护的羧基(低级)烯酰基,任选取代的杂环羰基(低级) 任选取代的杂环羰基(低级)烷酰基; R 2表示任选取代的芳基; R 3表示酰基。